Cape, I am going to copy a post I found on AOL to update you whats up at MSON.....the poster, Wesley, always seems to be very well informed on this company.........
"Subject: MSON Update
Date: Wed, Jan 7, 1998 16:49 EST
From: Wesley0428
Message-id: <19980107214900.QAA23746@ladder01.news.aol.com>
The stock price seems to expect a lousy Q2 and the loss of the USS manufacturing contract for cannulas.
Q2 won't be so bad and, so far, the contract with USS for cannula manufacturing is still in place and Misonix is shipping aggressively against that contract.
Despite the announced drop off in Lysonix demand, I expect Q2 revenues to match or exceed Q1. Q3 revenues should resume excellent growth rates. I'm looking fo $.12 for Q2, obviously a lower number than before we learned of the Lysonix inventory problems, but less of a disaster than I think the current stock price reflects. The only analyst following MSON is looking for $.10.
I've also heard rumors that MDA is interested in acquiring Misonix. I have multiple sources who have heard this rumor. Most of those sources don't believe it and Misonix says no discussions have taken place. For what it's worth, I think it true, but that doesn't mean it'll necessarily occur. Remember MDA is in the process of going public via a reverse merger with Direct Connect (KIDZ). I would assume they would wait until that merger is complete (I'm
hearing March), before talking to Misonix.
Bottom line is I'm very comfortable holding MSON at this price, much more upside than downside.
Expect earnings by Jan. 23 at latest. "
|
